GlassScriptPhysician profile
Adam A Golas
NPI 1114288792
$20,475.84
in general payments reported to CMS, 2019-2025
11 companies · $2,286 in 2025
The $2,286 reported for 2025 was more than what 83% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.38 · 2021: $481 · 2022: $2,056 · 2023: $2,683 · 2024: $13K · 2025: $2,286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $4,965 · Travel and Lodging: $908 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $4,965.12 |
| Travel and Lodging | $907.89 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,568.03 | 2021-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Medtronic, INC. | $767.24 | 2022-2023 | Signia, Ligasure |
| W. L. Gore & Associates, INC. | $674.31 | 2022-2024 | Seamguard Staple Line Reinforcement, Gore Seamguard Bioabsorbable Staple Line Reinforce, Seamguard |
| Teleflex LLC | $416.59 | 2024-2025 | Titan Sgs, Deknatel |
| Conmed Corporation | $325.09 | 2024 | Airseal |
| Ethicon US, LLC | $305.81 | 2022-2024 | Echelon Flex |
| Novo Nordisk INC | $151.67 | 2022-2025 | Wegovy |
| Baxter Healthcare | $147.34 | 2022-2025 | Seprafilm |
| Medical Device Business Services, INC. | $57.45 | 2022 | |
| Davol INC. | $40.38 | 2019 | |
| Abbott Laboratories | $21.93 | 2024 | Jeti Peripheral Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Golas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.